Renal Cell Carcinoma: Clinical Updates in Combination Therapy Strategies and an Introduction to Digital Patient Management

Renal Cell Carcinoma: Clinical Updates in Combination Therapy Strategies and an Introduction to Digital Patient Management

Online Digital Article

Faculty

Megan Hinkley, PharmD, BCOP
Clinical Specialist Pharmacist – Oncology
Department of Pharmacy
The James Cancer Hospital at The Ohio State University Wexner Medical Center
Columbus, Ohio
 
Program Description

Renal cell carcinoma accounts for up to 85% of kidney cancer tumors, of which the majority are clear cell histology. The 5-year overall survival for metastatic disease is just 12%. Combinations of targeted therapy agents, including tyrosine kinase inhibitors, anti-vascular endothelial growth factor inhibitors, and immune checkpoint inhibitors have been recently approved, and multiple other regimens are under investigation. Pharmacists should understand nuances of therapies and where regimens fit into treatment guidelines for mccRCC. The treatment paradigm for patients continues to shift toward oral oncolytics and use of orals in combination with intravenous therapies, making the role of the pharmacist in the management of these patients more challenging. This activity will present the role of digital applications and technology as tools for pharmacists to help coordinate care and manage patients with renal cell carcinoma.


Target Audience: Health-system, oncology, and specialty pharmacists
Type of Activity: Application
Release date: April 15, 2021
Expiration date: October 15, 2021
Time to complete activity: 2.0 hours
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Examine evidence supporting the current guidelines and recommendations for the use of combination therapies in metastatic clear cell renal cell carcinoma (mmcRCC)
• Analyze the safety and efficacy data of investigational combination strategies for first-line treatment of mccRCC and immune checkpoint inhibitor rechallenge
• Differentiate digital technology available to help manage patients with mccRCC

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-21-083-H01-P. The activity is available for CE credit through October 15, 2021.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Megan Hinkley, PharmD, BCOP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy H. Seung, PharmD, BCOP, FHOPA, BCPS; Ann Marciano; Kelly McCormick; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms